Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis
1998-01-01 Vikhanskaya, F; Vignati, S; Beccaglia, P; Ottoboni, C; Russo, P; D'Incalci, M; Broggini, M
A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS
1985-01-01 D'Incalci, M; Szmigiero, L; Erickson, Lc; Hartley, Ja; Kohn, Kw
Modulation of response to cancer chemotherapeutic agents by diet constituents - Is the available evidence sufficiently robust for rational advice for patients?
2007-01-01 D'Incalci, M; Steward, Wp; Gescher, Aj
OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations
2016-01-01 Riveiro, Me; Astorgues-Xerri, L; Vazquez, R; Frapolli, R; Kwee, I; Rinaldi, A; Odore, E; Rezai, K; Bekradda, M; Inghirami, G; D'Incalci, M; Noel, K; Cvitkovic, E; Raymond, E; Bertoni, F
Adjuvant 5-FU based chemotherapy for colon cancer: Match or miss the mismatch?
2009-01-01 D'Incalci, M
ET-743 and cisplatin (DDP) show in vitro and in vivo synergy against human sarcoma and ovarian carcinoma cell lines
2001-01-01 Erba, E; Muratore, I; Tiozzo, G; Ubezio, P; Colombo, T; Nicoletti, I; Giavazzi, R; Zucchetti, M; Damia, G; Meco, D; Riccardi, R; Faircloth, Gt; Jimeno, J; D'Incalci, M
Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials
2011-01-01 Sulaiman, Gm; Al Sammarrae, Kw; Ad'Hiah, Ah; Zucchetti, M; Frapolli, R; Bello, E; Erba, E; D'Incalci, M; Bagnati, R
Tumor-associated macrophages and anti-tumor therapies: complex links
2016-01-01 Belgiovine, C; D'Incalci, M; Allavena, P; Frapolli, R
DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1/CIP1 GENES
1995-01-01 Vikhanskaya, F; D'Incalci, M; Broggini, M
DNA-topoisomerase I activity and content in epithelial ovarian cancer
1998-01-01 Codegoni, Am; Castagna, S; Mangioni, C; Scovassi, Ai; Broggini, M; D'Incalci, M
Identification of a gene expression driven progression pathway in Myxoid liposarcoma
2014-01-01 De Cecco, L; Negri, T; Brich, S; Mauro, V; Bozzi, F; Dagrada, G; Disciglio, V; Sanfilippo, R; Gronchi, A; D'Incalci, M; Casali, Pg; Canevari, S; Pierotti, Ma; Pilotti, S
HORSERADISH-PEROXIDASE HYDROGEN PEROXIDE-CATALYZED OXIDATION OF VP16-213 - IDENTIFICATION OF A NEW METABOLITE
1985-01-01 Broggini, M; Rossi, C; Benfenati, E; D'Incalci, M; Fanelli, R; Gariboldi, P
Myxoid liposarcoma tumors with different chimera subtypes xenografted in nude mice are characterized by different response to trabectedin and gene expression profile
2010-01-01 Marchini, S; Frapolli, R; Nerini, If; Pilotti, S; Casali, P; Grosso, F; Sanfilippo, R; Gronchi, A; Tercero, Jc; D'Incalci, M
Definition of the least toxic sequence (LTS) and optimal therapeutic dose of Yondelis (TM) (ET-743; trabectedin) in combination with doxorubicin (Doxo) in patients with untreated metastatic soft tissue sarcomas (STS) and advanced pre-treated anthracycline - Naive breast cancer patients (ABC)
2003-01-01 Gianni, L; Grasselli, G; De Braud, F; Curigliano, G; Noberasco, C; Marsoni, S; Bartosek, A; Perez, C; Jimeno, J; Zucchetti, M; D'Incalci, M; Vigano, L; Bianchini, G; Sessa, C
Analysis of Differential miRNA Expression in Primary Tumor and Stroma of Colorectal Cancer Patients
2014-01-01 Scarpati, Gdv; Calura, E; Di Marino, M; Romualdi, C; Beltrame, L; Malapelle, U; Troncone, G; De Stefano, A; Pepe, S; De Placido, S; D'Incalci, M; Marchini, S; Carlomagno, C
Mode of action of trabectedin in myxoid liposarcomas
2014-01-01 Di Giandomenico, S; Frapolli, R; Bello, E; Uboldi, S; Licandro, Sa; Marchini, S; Beltrame, L; Brich, S; Mauro, V; Tamborini, E; Pilotti, S; Casali, Pg; Grosso, F; Sanfilippo, R; Gronchi, A; Mantovani, R; Gatta, R; Galmarini, Cm; Sousa-Faro, Jmf; D'Incalci, M
Translocation-Related Sarcomas
2009-01-01 Mertens, F; Antonescu, Cr; Hohenberger, P; Ladanyi, M; Modena, P; D'Incalci, M; Casali, Pg; Aglietta, M; Alvegard, T
Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis
1997-01-01 Arboix, M; Paz, Og; Colombo, T; D'Incalci, M
The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer
2012-01-01 Marchini, S; Poynor, E; Barakat, Rr; Clivio, L; Cinquini, M; Fruscio, R; Porcu, L; Bussani, C; D'Incalci, M; Erba, E; Romano, M; Cattoretti, G; Katsaros, D; Koff, A; Luzzatto, L
Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality?
2017-01-01 Tomao, F; D'Incalci, M; Biagioli, E; Peccatori, Fa; Colombo, N
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Inactivation of p53 in a human ovarian cancer cell line increases the sensitivity to paclitaxel by inducing G2/M arrest and apoptosis | 1-gen-1998 | Vikhanskaya, F; Vignati, S; Beccaglia, P; Ottoboni, C; Russo, P; D'Incalci, M; Broggini, M | |
| A FILTER INCUBATION METHOD FOR THE DETERMINATION OF POTENTIALLY CROSSLINKABLE SITES IN DNA IN MAMMALIAN-CELLS | 1-gen-1985 | D'Incalci, M; Szmigiero, L; Erickson, Lc; Hartley, Ja; Kohn, Kw | |
| Modulation of response to cancer chemotherapeutic agents by diet constituents - Is the available evidence sufficiently robust for rational advice for patients? | 1-gen-2007 | D'Incalci, M; Steward, Wp; Gescher, Aj | |
| OTX015 (MK-8628), a novel BET inhibitor, exhibits antitumor activity in non-small cell and small cell lung cancer models harboring different oncogenic mutations | 1-gen-2016 | Riveiro, Me; Astorgues-Xerri, L; Vazquez, R; Frapolli, R; Kwee, I; Rinaldi, A; Odore, E; Rezai, K; Bekradda, M; Inghirami, G; D'Incalci, M; Noel, K; Cvitkovic, E; Raymond, E; Bertoni, F | |
| Adjuvant 5-FU based chemotherapy for colon cancer: Match or miss the mismatch? | 1-gen-2009 | D'Incalci, M | |
| ET-743 and cisplatin (DDP) show in vitro and in vivo synergy against human sarcoma and ovarian carcinoma cell lines | 1-gen-2001 | Erba, E; Muratore, I; Tiozzo, G; Ubezio, P; Colombo, T; Nicoletti, I; Giavazzi, R; Zucchetti, M; Damia, G; Meco, D; Riccardi, R; Faircloth, Gt; Jimeno, J; D'Incalci, M | |
| Chemical characterization of Iraqi propolis samples and assessing their antioxidant potentials | 1-gen-2011 | Sulaiman, Gm; Al Sammarrae, Kw; Ad'Hiah, Ah; Zucchetti, M; Frapolli, R; Bello, E; Erba, E; D'Incalci, M; Bagnati, R | |
| Tumor-associated macrophages and anti-tumor therapies: complex links | 1-gen-2016 | Belgiovine, C; D'Incalci, M; Allavena, P; Frapolli, R | |
| DECREASED CYTOTOXIC EFFECTS OF DOXORUBICIN IN A HUMAN OVARIAN CANCER-CELL LINE EXPRESSING WILD-TYPE P53 AND WAF1/CIP1 GENES | 1-gen-1995 | Vikhanskaya, F; D'Incalci, M; Broggini, M | |
| DNA-topoisomerase I activity and content in epithelial ovarian cancer | 1-gen-1998 | Codegoni, Am; Castagna, S; Mangioni, C; Scovassi, Ai; Broggini, M; D'Incalci, M | |
| Identification of a gene expression driven progression pathway in Myxoid liposarcoma | 1-gen-2014 | De Cecco, L; Negri, T; Brich, S; Mauro, V; Bozzi, F; Dagrada, G; Disciglio, V; Sanfilippo, R; Gronchi, A; D'Incalci, M; Casali, Pg; Canevari, S; Pierotti, Ma; Pilotti, S | |
| HORSERADISH-PEROXIDASE HYDROGEN PEROXIDE-CATALYZED OXIDATION OF VP16-213 - IDENTIFICATION OF A NEW METABOLITE | 1-gen-1985 | Broggini, M; Rossi, C; Benfenati, E; D'Incalci, M; Fanelli, R; Gariboldi, P | |
| Myxoid liposarcoma tumors with different chimera subtypes xenografted in nude mice are characterized by different response to trabectedin and gene expression profile | 1-gen-2010 | Marchini, S; Frapolli, R; Nerini, If; Pilotti, S; Casali, P; Grosso, F; Sanfilippo, R; Gronchi, A; Tercero, Jc; D'Incalci, M | |
| Definition of the least toxic sequence (LTS) and optimal therapeutic dose of Yondelis (TM) (ET-743; trabectedin) in combination with doxorubicin (Doxo) in patients with untreated metastatic soft tissue sarcomas (STS) and advanced pre-treated anthracycline - Naive breast cancer patients (ABC) | 1-gen-2003 | Gianni, L; Grasselli, G; De Braud, F; Curigliano, G; Noberasco, C; Marsoni, S; Bartosek, A; Perez, C; Jimeno, J; Zucchetti, M; D'Incalci, M; Vigano, L; Bianchini, G; Sessa, C | |
| Analysis of Differential miRNA Expression in Primary Tumor and Stroma of Colorectal Cancer Patients | 1-gen-2014 | Scarpati, Gdv; Calura, E; Di Marino, M; Romualdi, C; Beltrame, L; Malapelle, U; Troncone, G; De Stefano, A; Pepe, S; De Placido, S; D'Incalci, M; Marchini, S; Carlomagno, C | |
| Mode of action of trabectedin in myxoid liposarcomas | 1-gen-2014 | Di Giandomenico, S; Frapolli, R; Bello, E; Uboldi, S; Licandro, Sa; Marchini, S; Beltrame, L; Brich, S; Mauro, V; Tamborini, E; Pilotti, S; Casali, Pg; Grosso, F; Sanfilippo, R; Gronchi, A; Mantovani, R; Gatta, R; Galmarini, Cm; Sousa-Faro, Jmf; D'Incalci, M | |
| Translocation-Related Sarcomas | 1-gen-2009 | Mertens, F; Antonescu, Cr; Hohenberger, P; Ladanyi, M; Modena, P; D'Incalci, M; Casali, Pg; Aglietta, M; Alvegard, T | |
| Multidrug resistance-reversing agents increase vinblastine distribution in normal tissues expressing the P-glycoprotein but do not enhance drug penetration in brain and testis | 1-gen-1997 | Arboix, M; Paz, Og; Colombo, T; D'Incalci, M | |
| The Zinc Finger Gene ZIC2 Has Features of an Oncogene and Its Overexpression Correlates Strongly with the Clinical Course of Epithelial Ovarian Cancer | 1-gen-2012 | Marchini, S; Poynor, E; Barakat, Rr; Clivio, L; Cinquini, M; Fruscio, R; Porcu, L; Bussani, C; D'Incalci, M; Erba, E; Romano, M; Cattoretti, G; Katsaros, D; Koff, A; Luzzatto, L | |
| Restoring platinum sensitivity in recurrent ovarian cancer by extending the platinum-free interval: Myth or reality? | 1-gen-2017 | Tomao, F; D'Incalci, M; Biagioli, E; Peccatori, Fa; Colombo, N |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista26919
Data di pubblicazione
- In corso di stampa6
- 2020 - 20269123
- 2010 - 201911532
- 2000 - 20094500
- 1990 - 19991429
- 1980 - 1989306
- 1975 - 197923
Editore
- Edition AERCV1
- Elsevier1
- Futura Publishing Company1
- Grafica Luigi Monti s.r.l.1
- Karger, Basel1
- Mosby1
- sn1
- Springer-Verlag1
- Thieme1
Rivista
- DIGESTIVE AND LIVER DISEASE368
- EUROPEAN JOURNAL OF NUCLEAR MEDIC...258
- ANNALS OF ONCOLOGY243
- CANCERS228
- THE JOURNAL OF NUCLEAR MEDICINE220
- PLOS ONE212
- EUROPEAN JOURNAL OF CANCER205
- GASTROINTESTINAL ENDOSCOPY193
- JOURNAL OF CLINICAL MEDICINE184
- ALLERGY180
Keyword
- Humans2101
- Female1005
- Male964
- Middle Aged745
- Aged643
- Adult550
- COVID-19415
- Treatment Outcome359
- Animals321
- Retrospective Studies262
Lingua
- eng19197
- ita408
- spa14
- fre11
- ger8
- enm3
- por2
- chi1
Accesso al fulltext
- no fulltext24666
- reserved1362
- open891